PL Developments Competitors and Similar CompaniesClear all

PL Developments's competitors and similar companies include kindroot, Alembic Pharmaceuticals and UCB.

	PL Developments PL Developments is a company specializing in solid and liquid dose remedies.	kindroot kindroot is a company that offers functional plant-based lozenges.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 1988	Founding Date 2018	Founding Date 2010	Founding Date 1928
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare ecommerce fitness & wellness supplements	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Westbury, US HQ Clinton, US Copiague, US Copiague, US Copiague, US Doral, US Doral, US see more	Locations El Segundo, US HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 5272% increase	Employees 1	Employees 14,858	Employees 9,052
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit €7.2b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income €1.6b (FY, 2025)
Operating ⚠
Products	Products N/A	Products 5 (Aug, 2020)	Products 145 (FY, 2024)	Products N/A